Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01508676 · ClinicalTrials.gov registry record · NA
Effects of Pennsaid on Clinical Neuropathic Pain
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01508676: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01508676 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01508676, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo.
Interventions
- DRUG Pennsaid
- DRUG Placebo (2.3% DMSO solution)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01508676
The ClinicalTrials.gov registry entry for NCT01508676 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pennsaid is the first listed.
NCT01508676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01508676 about?
NCT01508676 is a clinical study titled "Effects of Pennsaid on Clinical Neuropathic Pain". The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA...
What is the current status of trial NCT01508676?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2011-11. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01508676?
The interventions under investigation include: Pennsaid (DRUG), Placebo (2.3% DMSO solution) (DRUG).
Who is sponsoring clinical trial NCT01508676?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.